Editor's Corner
Comments
I was involved with an Epic implementation and I saw the exact same writing on the wall within months of the project kick off.
Epic has infiltrated the Twin Cities hospital market to the point that if you don't implement Epic, you'll lose business.
So all these hospital systems are looking a keeping business, but not looking at the safety of the patients.
Interesting.
Read your Editor's Corner and I have to comment as a user of the Epic EMR within Northern California Kaiser for the past year. It works fine. Yes, there are slightly different versions of Epic running in different regions but from an end-user point of view, they are perfectly integrated. As new regions are started on the EMR, upgraded versions are used that have updated and better features, and very slowly these are upgraded on older versions. I can request a chart from another region and you can see it requested, then opens up, you add whatever documentation you need, and when closed, it is sent off to the home medical center. It is seamless. We have had no significant down time the past year in Northern Claifornia from my perspective. None. Despite what has been reported by non-Epic users. And the EMR does not prevent us from doing what we were trained to do, take care of patients. We still do the same things we did when we were trained. You examine and talk to the patient, order labs or studies, make the diagnosis and initiate treatment. The EMR is convenient for documentation and historical data retrieval, it adds a little more work to our workflow, but does not change our focus at all, the patient is still the primary concern. We have several back-up systems in place if we need them, but there is nothing different in what we have ever done. IMHO, as a user, the concerns and complaints are overblown and do not deserve the attention it is getting.
Post new comment
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies






